
Germany · Research startup
Cellex Cell Professionals GmbH is a full-service Contract Development and Manufacturing Organization (CDMO) based in Cologne, Germany.
Funding reportedLast round: Private Equity
Cellex Cell Professionals GmbH is a full-service Contract Development and Manufacturing Organization (CDMO) based in Cologne, Germany.
Founded in 2001 by Prof. Dr. Gerhard Ehninger, the company specializes in Cell and Gene Therapy (CGT) and has over 24 years of experience in the biotechnology sector. Cellex operates GMP-compliant facilities that are fully automated and designed for the manufacturing of autologous and allogeneic cell therapy products. The company offers a wide range of services, including process development, clinical and commercial manufacturing, and regulatory support. Cellex is known for its expertise in producing CAR-T cell products, hematopoietic blood stem cells, and other advanced therapeutic modalities. It serves a diverse clientele, including major pharmaceutical companies, biotech firms, and academic institutions, providing tailored solutions from pre-clinical development through to commercialization. With a commitment to quality and innovation, Cellex has established itself as a trusted partner in the global CGT landscape.
Funding, as reported
What they build
Known for
prozessentwicklung und optimierungtransport logistikbiotechnology researchklinische studienforschung entwicklungherstellung autologer und allogener zelltherapieproduktemedicalcar t cellscdmo fuer zell und gentherapieprozessvalidierungzellentnahmenknochenmarkentnahmenherstellung von cgtproduktenzell und gentherapieautologe und allogene zellgewinnungpharmaceuticals
Built with from their website
AtlassianMicrosoft Windows Server 2012Microsoft Exchange OnlineAzure DNSApple Business ManagerMicrosoft ExchangeMicrosoft 365Microsoft AzureOutlookMicrosoft 365 Apps & Services
Microsoft Email ProvidersApple School Manager
Add your raise, your deck and your story, and put Cellex Cell Professionals in front of investors. Or tell us what we have wrong.